Bonne Adams's most recent trade in TRACON Pharmaceuticals Inc was a trade of 99,000 Employee Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Feb. 1, 2023.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
TRACON Pharmaceuticals Inc | Bonne Adams | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2023 | 99,000 | 99,000 | - | - | Employee Stock Option (Right to Buy) |